Conclusion
Guillain-Barre Syndrome (GBS) is oftentimes a post-infectious immune-mediated radiculopathy that commonly results in neuromuscular respiratory failure. We present a rare case of GBS secondary to COVID-19 infection. Clinicians should consider COVID-19 as a viral infection that can trigger immune-mediated pathologies such as GBS. More investigation is warranted to further understand the pathophysiology relating GBS and COVID-19.